How to diagnose antibiotic resistance
For targeted and efficient treatment of bacterial infections, the pathogens and their resistance patterns must be identified as quickly as possible. This is the only way to successfully treat the diseases without promoting the emergence of new antibiotic resistance. Empa researchers are working on a variety of innovative technologies that allow faster and more precise diagnostics and thus timely, customized treatment.

What are the current problems in the diagnosis of antibiotic resistance?
Currently, the diagnosis of bacterial infections is usually based on growing bacteria in microbiological cultures in the laboratory, which is labor-intensive and time-consuming (1-4 days). For some bacteria, such as the slow-growing tuberculosis bacterium Mycobacterium tuberculosis, this can take even longer. This means that antibiotic treatment is usually started before the laboratory results are received and the choice of medication is therefore based on a guess. This is one of the causes of the increasing development of antibiotic resistance: As the bacteria thus come into contact with “inappropriate” antibiotics, they can subsequently develop resistance to these agents.
Researchers are therefore very interested in speeding up the diagnostic process. There are a number of approaches to automate the process. While these efforts are promising, they still rely on microbiological culture (1-2 days) to enrich the bacteria for appropriate detection.
The ideal diagnostic test should identify the specific pathogen much more quickly and indicate an appropriate therapy based on the antibiotic resistance pattern. This is particularly important for diseases such as pneumonia and blood poisoning (sepsis), which can be caused by many different pathogens (viruses, bacteria or fungi) and in which antibiotic resistance is particularly common.
What are the trends for innovative diagnostics of antibiotic resistance?
Recent innovations in bacterial diagnostics have significantly improved the speed and accuracy of identifying antibiotic-resistant pathogens. Rapid molecular diagnostics such as PCR and second-generation sequencing enable rapid and precise identification of bacterial pathogens and their resistance genes. However, it is often necessary to first enrich bacteria in clinical samples, which in turn prolongs the process.
For this reason, biosensors are currently being developed to detect bacterial infections directly, for example using antibodies and protein components that can bind to the bacteria precisely and quickly. These biosensors can be integrated into wearable devices, for example, to monitor infections in real time.
AI and specific algorithms are also increasingly being used to analyze diagnostic data. These technologies can help identify patterns in bacterial resistance and predict resistance profiles, improving diagnostic accuracy and treatment planning.

A selection of research projects on the diagnosis of antibiotic resistance
Peptide nanosensor
Ultrafast Determination of Antimicrobial Resistant Staphylococcus aureus Specifically Captured by Functionalized Magnetic Nanoclusters
Specific capture of Pseudomonas aeruginosa for rapid detection of antimicrobial resistance in urinary tract infections
A rapid and specific antimicrobial resistance detection of Escherichia coli via magnetic nanoclusters
Biosensors
Lab-on-a-Fiber Wearable Multi-Sensor for Monitoring Wound Healing
Bacterial Sensors
Fluorescent Probe for the pH-Independent Rapid and Sensitive Direct Detection of Urease-Producing Bacteria
Infection sensors
Dr. Qun Ren
Biointerfaces
Phone +41 58 765 7688
Wound healing sensors
Dr. Luciano Boesel
Biomimetic Membranes and Textiles
Phone: +41 58 765 7393
-
Share